Skip to main content
Veterinary Medicines

Mastijet Forte, Intramamární suspenze

Authorised
  • Tetracycline hydrochloride
  • Neomycin
  • Bacitracin
  • Prednisolone

Product identification

Medicine name:
Mastijet Forte, Intramamární suspenze
Active substance:
  • Tetracycline hydrochloride
  • Neomycin
  • Bacitracin
  • Prednisolone
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    200.00
    milligram(s)
    /
    1.00
    Applicator
  • Neomycin
    250.00
    milligram(s)
    /
    1.00
    Applicator
  • Bacitracin
    2000.00
    international unit(s)
    /
    1.00
    Applicator
  • Prednisolone
    10.00
    milligram(s)
    /
    1.00
    Applicator
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        21
        day
      • Milk
        120
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 96/055/01-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 11/07/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 11/07/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 11/07/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."